CXCR4 and head and neck squamous cell carcinoma: Thus, T22-PE24-H6 and T22-DITOX-H6 nanotoxin treatment at the chosen administration conditions, does not induce off-target toxicity in the CXCR4+ HNSCC subcutaneous mouse model.